Mousavi, Bentolhoda, Bathaie, Seyedeh zahra, Fadai, Farbod, Ashtari, Zabihollah, Ali beigi, Neda, farhang, Sara, Hashempour, Sara, Shahhamzei, Nasim, Heidarzadeh, Hamid. (1394). Safety evaluation of saffron stigma (Crocus sativus L.) aqueous extract and crocin in patients with schizophrenia. , 5(5), 413-419. doi: 10.22038/ajp.2015.3879
Bentolhoda Mousavi; Seyedeh zahra Bathaie; Farbod Fadai; Zabihollah Ashtari; Neda Ali beigi; Sara farhang; Sara Hashempour; Nasim Shahhamzei; Hamid Heidarzadeh. "Safety evaluation of saffron stigma (Crocus sativus L.) aqueous extract and crocin in patients with schizophrenia". , 5, 5, 1394, 413-419. doi: 10.22038/ajp.2015.3879
Mousavi, Bentolhoda, Bathaie, Seyedeh zahra, Fadai, Farbod, Ashtari, Zabihollah, Ali beigi, Neda, farhang, Sara, Hashempour, Sara, Shahhamzei, Nasim, Heidarzadeh, Hamid. (1394). 'Safety evaluation of saffron stigma (Crocus sativus L.) aqueous extract and crocin in patients with schizophrenia', , 5(5), pp. 413-419. doi: 10.22038/ajp.2015.3879
Mousavi, Bentolhoda, Bathaie, Seyedeh zahra, Fadai, Farbod, Ashtari, Zabihollah, Ali beigi, Neda, farhang, Sara, Hashempour, Sara, Shahhamzei, Nasim, Heidarzadeh, Hamid. Safety evaluation of saffron stigma (Crocus sativus L.) aqueous extract and crocin in patients with schizophrenia. , 1394; 5(5): 413-419. doi: 10.22038/ajp.2015.3879

Safety evaluation of saffron stigma (Crocus sativus L.) aqueous extract and crocin in patients with schizophrenia

Avicenna Journal of Phytomedicine
مقاله 5، دوره 5، شماره 5، آذر و دی 2015، صفحه 413-419    اصل مقاله (454.18 K)
نوع مقاله: Original Research Article
شناسه دیجیتال (DOI): 10.22038/ajp.2015.3879
نویسندگان
Bentolhoda Mousavi1؛ Seyedeh zahra Bathaie* 2؛ Farbod Fadai1؛ Zabihollah Ashtari1؛ Neda Ali beigi1؛ Sara farhang3؛ Sara Hashempour1؛ Nasim Shahhamzei2؛ Hamid Heidarzadeh2
1Department of Psychiatry, University of Social Welfare and Rehabilitation Sciences, P.O.Box: 1985713834, Tehran, Iran
2Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, P.O.Box: 14115-111, Tehran, Iran
3Clinical psychiatry research center, Tabriz University of Medical Sciences, Tabriz, Iran
چکیده
Objectives: Saffron is the stigma of Crocus sativus L., which has the potentials to play a role in the treatment of many diseases. Although many researches are now going on this precious spice, there are few data on saffron safety in human, especially in patients with chronic mental illnesses. This study aimed to evaluate the short-term safety and tolerability of both saffron and crocin (its major constituent) in adult patients with schizophrenia.
Materials and Methods: The capsules of saffron aqueous extract (SAE) and crocin were used to evaluate short-term safety and tolerability in patients with schizophrenia. A double-blind, placebo-controlled study was performed on patients with schizophrenia. The patients were all male and were divided into three 22-patient groups. While receiving their normal treatment, they also received a 12 week treatment with SAE (15 mg twice daily), crocin (15 mg twice daily) or placebo.
Results: A total of 61 patients completed the trial; none of them reported a serious side effect. WBC count increased significantly in patients receiving saffron aqua extract (SAE), but it was within the normal range and had no clinical significance. Other hematologic components, markers of thyroid, liver and kidney or inflammation markers had no statistically significant difference among the groups.
Conclusions: This study showed that SAE and crocin in doses of 15 mg twice daily were safely tolerated in patients with schizophrenia.
کلیدواژه‌ها
Saffron Aqueous Extract؛ Crocin؛ Clinical trial؛ Safety assessment؛ Schizophrenia
مراجع
آمار
تعداد مشاهده مقاله: 35,537
تعداد دریافت فایل اصل مقاله: 11,053
دانشگاه علوم پزشکی مشهد
آمار
تعداد نشریات29
تعداد شماره‌ها2,319
تعداد مقالات24,808
تعداد مشاهده مقاله82,218,098
تعداد دریافت فایل اصل مقاله45,441,285